相关实验视频
Updated: Jul 19, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
182
在性结肠炎患者中,夜痛和便秘的严重程度
Yasunori Yamamoto1, Shinya Furukawa2, Teruki Miyake3
1Endoscopy Center, Ehime University Hospital, Toon, Ehime, Japan.
Urology
|August 14, 2023
概括
夜尿,或夜间排尿,与性结肠炎 (UC) 患者的便秘有关. 增加夜尿症的严重程度与UC管理中经历便秘的可能性更高相关.
科学领域:
- 胃肠病学 胃肠病学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 内部医学 内部医学
背景情况:
- 便秘是性结肠炎 (UC) 管理中的新兴症状.
- 众所周知,夜尿症在一般人群中与便秘有关,但这种联系在UC患者中尚不清楚.
研究的目的:
- 在被诊断患有性结肠炎 (UC) 的患者中调查夜尿和便秘之间的关联.
主要方法:
- 一系列连续的290名日本UC患者完成了关于便秘,夜和生活方式的自我管理问卷.
- 便秘是使用罗马I标准和/或药物使用来定义的.
- 夜尿症的严重程度分为没有,轻度 (一次) 和严重 (两次或更多次) 的夜间排尿.
主要成果:
- 在所有UC患者中,便秘的患病率为12.4%.
- 便秘的患病率随着夜的严重程度而增加:没有夜的情况为8.2%,轻度夜的情况为10.8%,严重夜的情况为20.5%.
- 经过对混因素进行调整后,夜的严重程度与便秘独立相关 (严重夜的调整OR为3.19;趋势的P=.035).
结论:
- 晚的严重程度与性结肠炎患者的便秘有关.
- 在治疗UC患者时,医生应考虑夜和便秘之间的相互作用.
更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
210
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
210
Drugs for Treatment of Diarrhea-Predominant IBS
213
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
213
Inflammatory Bowel Disease I: Ulcerative Colitis
215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Urinary Tract Calculi V: Nursing Management
14
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
14
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485

